FDA Adverse Event Injury Summary report: N

XIENCE V EVEROLIMUS ELUTING CORONARY STENT SYSTEM

MDR report key: 2141851 · Received June 27, 2011

Report

Report Number
2024168-2011-04517
Event Type
Injury
Date Received
June 27, 2011
Date of Event
June 2, 2011
Report Date
June 2, 2011
Manufacturer
AV-TEMECULA-CT
Product Code
NIQ
PMA / PMN Number
P070015
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
GA, US
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

(B)(4). DURING PROCESSING OF THIS COMPLAINT, ATTEMPTS WERE MADE TO OBTAIN COMPLETE EVENT, PATIENT AND DEVICE INFORMATION. THERE WAS NO REPORTED PRODUCT DEFICIENCY. THE REPORTED ANGINA AND THROMBOSIS ARE LISTED IN THE INSTRUCTIONS FOR USE AS A KNOWN ADVERSE EVENT ASSOCIATED WITH CORONARY STENTING. ALTHOUGH A CONCLUSIVE CAUSE FOR THE REPORTED PATIENT EFFECTS, AND THE RELATIONSHIP TO THE PRODUCT, IF ANY, CANNOT BE DETERMINED, THERE IS NO INDICATION OF A PRODUCT QUALITY DEFICIENCY WITH RESPECT TO MANUFACTURING, DESIGN OR LABELING AND THE TREATMENT APPEARS TO BE RELATED TO THE OPERATIONAL CONTEXT OF THE PROCEDURE.

Description of Event or Problem · 1

IT WAS REPORTED THAT ABOUT 1 1/2 TO 2 HOURS POST-PROCEDURE OF A XIENCE V IMPLANT OF THE MODERATELY TORTUOUS MID LEFT ANTERIOR DESCENDING (LAD) ARTERY, STENT THROMBOSIS OCCURRED. IT WAS NOTED THAT THE PATIENT COMPLAINED OF CHEST PAIN AND THE ANGIOGRAM REVEALED CLOT IN THE STENTED AREA. A NON-ABBOTT ASPIRATION DEVICE WAS USED AND A NON-ABBOTT EXTRACTION DEVICE WAS USED TO REMOVE THE THROMBOSIS. A 4.0 X 15 MM XIENCE STENT WAS PLACED IN THE PROXIMAL AREA OF THE VESSEL BETWEEN A PREVIOUS NON-ABBOTT PROXIMAL, PROXIMAL LAD STENT AND THE MID LAD STENT. THE PATIENT WAS REPORTED AS DOING FINE POST PROCEDURE. THOUGH REQUESTED, NO ADDITIONAL INFORMATION WAS PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 XIENCE V EVEROLIMUS ELUTING CORONARY STENT SYSTEM DRUG ELUTING CORONARY STENT SYSTEM NIQ AV-TEMECULA-CT 0101241

Patients

Seq Age Sex Outcome Treatment
1 53 YR Required Intervention